葡萄牙牙,神经炎症和阿尔茨海默氏症的疾病
Prof Victor Owoyele1, Samira Malekzadeh2
1Associate Editor, NJPS. deleyele@yahoo.com.
概括
口腔细菌 Porphyromonas gingivalis 可能通过神经炎症导致阿尔茨海默氏症 (AD) 病变. 针对这种细菌的治疗方法对阿尔茨海默病和其他炎症状况有希望.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 口腔健康 口腔健康
背景情况:
- 口腔微生物群失调与各种疾病有关,包括痴呆症和阿尔茨海默氏症 (AD).
- 神经炎症是AD病变的主要驱动因素,特别是在老年人群中.
- 口腔细菌 Porphyromonas gingivalis (P. gingivalis) 引发免疫反应,导致炎症和细胞损伤.
结论:
- P. gingivalis与阿尔茨海默病和其他炎症状况的进展有关.
- 针对P. gingivalis的治疗策略,如牙痛抑制剂 (例如COR388,COR286),显示出预防大脑殖民和减少神经炎症的潜力.
- 保持口腔卫生和探索新型治疗方法对于管理P. gingivalis相关疾病至关重要.
相关概念视频
01:26Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195